Riskpilot← Back to searchSign inGet full accessDoctor RY AB
ABActiveOrg 5569960320Nordmannavägen 2General medical practice activities · NACE 8621Est. 20144 employees
Revenue 2025
SEK 9,7M
+6% vs 2024
EBITDA margin
18.0%
+28% vs 2024
Equity ratio
59.2%
Financial strength
Net profit 2025
SEK 1M
+16% vs 2024
| Revenue | SEK 9,7M | +6% |
| EBITDA | SEK 1,7M | +28% |
| Net profit | SEK 1M | +16% |
| Total assets | SEK 6,4M | +13% |
| Equity | SEK 3,8M | +9% |
| Employees | 4 | — |
Legal name
Doctor RY AB
Org number
5569960320
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 december 2014
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet inom hudbehandling och kirurgi och därmed förenlig verksamhet.
Address
Nordmannavägen 2
Email
reza@yazdanpanah.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 284 | 6 060 | 6 867 | 9 104 | 9 673 |
| Staff expenses | −2 195 | −1 898 | — | — | −3 746 |
| EBITDA | 1 778 | 2 521 | 2 159 | 1 367 | 1 743 |
| Depreciation & amort. | −149 | −158 | −24 | −51 | −47 |
| EBIT | 1 629 | 2 363 | 2 135 | 1 316 | 1 696 |
| Net financials | −1 | −1 | 42 | 119 | 55 |
| Profit before tax | 1 466 | 2 371 | 1 635 | 1 118 | 1 302 |
| Tax | −304 | −489 | −342 | −253 | −294 |
| Net profit | 1 162 | 1 881 | 1 293 | 865 | 1 008 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 304 | 3 622 | 4 700 | 5 642 | 6 354 |
| Equity | 1 563 | 2 894 | 3 187 | 3 452 | 3 760 |
| Long-term debt | — | — | 0 | 0 | — |
| Short-term debt | 679 | 674 | 918 | 1 280 | 1 234 |
| Total debt | 679 | 674 | 918 | 1 280 | 1 234 |
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
20212025
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
20212025
Return on equity
26.8%
This company
18.4%
Market median
+46% vs market
20212025
Net profit margin
10.4%
This company
8.1%
Market median
+28% vs market
20212025
Asset turnover
1.52×
This company
1.12×
Market median
+36% vs market
20212025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EC Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
MR Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doctor RY AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Rolf Hahnsjö | Audit | 0 companies |
| Emma Christina Lindén | Chief Auditor | 0 companies |
| Farnosh Salehpour | Deputy Board Member | 0 companies |
| Reza Yazdan Panah | Board of Directors | 0 companies |